Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 49 - Preparations for testing in vivo
Patents for A61K 49 - Preparations for testing in vivo (35,376)
10/2012
10/10/2012CN102716503A Medical ultrasonic coupling agent and preparation method thereof
10/10/2012CN102716502A Chitosan-supported adriamycin-organic fluorescence dye fluorescence resonance energy transfer (FRET) targeted composite probe
10/10/2012CN102716501A A method for screening toxicity of traditional Chinese medicine by model organism zebra fish
10/10/2012CN102178963B Medical ultrasonic couplant and preparation method of couplant
10/10/2012CN101090739B 1,4-bis(carboxymethyl)-6-[bis(carboxymethyl)amino]-6-methyl-perhydro-1,4-diazepine (aazta) derivatives as ligands in high relaxivity contrast agents for use in magnetic resonance imaging (mri)
10/10/2012CN101083907B Compositions and methods for topical diagnostic and therapeutic transport
10/10/2012CN101010002B Cancer selective auxotrophs
10/09/2012US8282550 Integrated receiver for continuous analyte sensor
10/09/2012CA2660425C Composition apparatus and method for use in imaging
10/09/2012CA2358517C Method and composition for angiogenesis inhibition
10/04/2012WO2012135562A2 Polymer conjugates targeting cells and methods related thereto
10/04/2012WO2012135432A2 Dyes for membranes and biological structures
10/04/2012WO2012133688A1 Method for detecting cancer cell using fluorescently labeled l-glucose derivative, and cancer cell-imaging agent comprising fluorescently labeled l-glucose derivative
10/04/2012WO2012133295A1 Bioabsorbable antiadhesive material containing contrast medium
10/04/2012WO2012132140A1 Ultrasound contrast agent
10/04/2012WO2012131106A1 Biodegradable compositions suitable for controlled release
10/04/2012WO2012131104A2 Biodegradable compositions suitable for controlled release
10/04/2012WO2012131018A1 Nanoparticles loaded with chemotherapeutic antitumoral drug
10/04/2012WO2012129668A1 Antibodies against kidney associated antigen 1 and antigen binding fragments thereof
10/04/2012WO2012100206A3 Mri markers, delivery and extraction systems, and methods of manufacture and use thereof
10/04/2012WO2012098226A3 Visualization of lipid metabolism
10/04/2012WO2012094541A3 Acoustically responsive particles with decreased cavitation threshold
10/04/2012WO2012087040A3 Conjugate for photodynamic diagnosis or therapy and method for preparing same
10/04/2012WO2011143524A3 Functional, cross-linked nanostructures for tandem optical imaging and therapy
10/04/2012US20120255041 Transgenic non-human animal and uses thereof
10/04/2012US20120253189 Cavity-filling biopsy site markers
10/04/2012US20120252868 Novel means and methods for the treatment of hearing loss and phantom hearing
10/04/2012US20120251559 Treatment of B-Cell Cancers With Anti-CD70 Antibody-Drug Conjugates
10/04/2012US20120251459 Specific inhibitors and active site probes for legumain
10/04/2012US20120251458 Dyes for Membranes and Biological Structures
10/04/2012US20120251457 Methods and compositions for modulating adipocyte function
10/04/2012US20120251456 Method for Assessing Skin Condition
10/04/2012US20120251455 Hair Growth-Inhibiting Agent
10/04/2012US20120251454 Human Anti-IL-23 Antibodies, Compositions, Methods and Uses
10/04/2012US20120251453 Methods and Compositions Related to Annexin 1-Binding Compounds
10/04/2012US20120251452 Apparatus and method for identifying one or more amyloid beta plaques in a plurality of discrete oct retinal layers
10/04/2012US20120251451 Renal Cell Carcinoma Biomarkers
10/04/2012US20120251450 Nanoparticles that preferentially associate with and kill diseased cells for diagnostic and therapeutic applications
10/04/2012US20120251448 Compounds for Use in the Detection of Neurodegenerative Diseases
10/04/2012US20120251445 Peptides whose uptake by cells is controllable
10/04/2012US20120251443 Implantable contrast agents and methods
10/04/2012US20120251439 Antigens Associated with Inflammatory Bowel Disease Including Ulcerative Colitis
10/04/2012CA2831471A1 Biodegradable compositions suitable for controlled release
10/04/2012CA2831469A1 Biodegradable compositions suitable for controlled release
10/04/2012CA2829105A1 Antibodies against kidney associated antigen 1 and antigen binding fragments thereof
10/03/2012EP2505211A1 Molecules for targeting compounds to various selected organs or tissues
10/03/2012EP2504022A1 Brain tumor targeting peptides and methods
10/03/2012EP2503990A1 Process for the preparation of gadobenate dimeglumine complex in a solid form
10/03/2012CN1950100B Multi-component biological transport systems
10/03/2012CN102711840A Liposome nanoparticles for tumor magnetic resonance imaging
10/03/2012CN102711839A In vivo screening assays
10/03/2012CN102711838A Molecular probe for imaging islets of langerhans, and use therefore
10/03/2012CN102703510A Carbon-coated magnetic nanoparticle gene transfection kit and purposes thereof
10/03/2012CN102703081A Water-soluble rare earth doped gadolinium sodium tetrafluoride fluorescent marked nano-crystal, and preparation method thereof
10/03/2012CN102703060A Targeted tracing noble metal fluorescence probe and anti-tumor prodrug
10/03/2012CN102698296A Gastrointestinal series agent
10/03/2012CN102698295A Preparation of diatrizoic-acid-modified double-element target CT (Computed Tomography) contrast agent containing gold and iodine
10/03/2012CN102698294A Chitosan-supported hydroxycamptothecine-quantum dot FRET (Fluorescence Resonance Energy Transfer) composite probe
10/03/2012CN102698293A Application of mTOR (mammalian Target of Rapamycin) serving as target to screening of medicament for treating nicotine addiction
10/03/2012CN102698292A Preparation method of animal model simulating human pelvic inflammatory disease (PID)
10/03/2012CN102698268A Electrically conductive macromolecular nano-material and application of electrically conductive macromolecular nano-material
10/03/2012CN102028961B Ultrasonic coupling agent used by traumatic patient after surgery
10/03/2012CN101885736B 5-aminolevulinic acid phosphate salt, process for producing the same and use thereof
10/03/2012CN101516405B 荧光化学传感器 Fluorescent chemical sensor
10/02/2012US8278265 Methods, kits and compositions comprising crotamine
10/02/2012US8277824 Solubilization of cyclohexane-based carboxamide derivatives for use as sensates in consumer products
10/02/2012US8277779 Compositions useful for reducing nephrotoxicity and methods of use thereof
10/02/2012US8277778 Vaccine adjuvants
09/2012
09/27/2012WO2012128504A2 Uridine-based gadolinium complex and mri contrast agent comprising same
09/27/2012WO2012128162A1 Silica nanoparticles for diagnostic imaging, method for manufacturing same, and labeling agent for biosubstance
09/27/2012WO2012127739A1 Novel carrier molecule and method both for delivering rna into cytoplasm using near-infrared light
09/27/2012WO2012126115A1 Star polymer nanoshells and methods of preparation thereof
09/27/2012WO2012070893A3 Single nanoparticle having a nanogap between a core material and a shell material, and manufacturing method thereof
09/27/2012US20120246746 Method for Generating Immune-Compatible Cells and Tissues Using Nuclear Transfer Techniques
09/27/2012US20120244081 Manganese chelates and their use as contrast agents in magnetic resonance imaging (mri)
09/27/2012US20120244080 Protein agent for diabetes treatment and beta cell imaging
09/27/2012US20120244079 Traceable retinoid acid for imaging, disease prevention and therapy
09/27/2012US20120244078 Optical imaging contrast agents and uses thereof
09/27/2012US20120244077 Methods and compositions for maintenance of a functional wound
09/27/2012US20120244076 csPCNA Isoform Antibodies And Uses Thereof
09/27/2012US20120244075 5 NM Nickel-NTA-Gold Nanoparticles
09/27/2012US20120244074 Labelled integrin binders
09/27/2012US20120244070 Fibronectin targeting contrast agent
09/27/2012US20120244068 Microorganisms for imaging and/or treatment of tumors
09/27/2012DE102011101680A1 Marker, useful for magnetic resonance tomography-visualization of medical devices e.g. catheters, needles, endoscopes or papillotomes insertable or implantable into body, comprises magnetic resonance tomography-contrast enhanced marking
09/27/2012CA2830908A1 Methods and compositions for improving antiangiogenic therapy with anti-integrins
09/26/2012EP2502938A2 Antibodies and immunoconjugates and uses therefor
09/26/2012EP2502882A1 Magnetic iron oxide microparticle powder, aqueous dispersion containing magnetic particles, and process for production of same
09/26/2012EP2501415A1 Liposome nanoparticles for tumor magnetic resonance imaging
09/26/2012CN102690785A Establishment and application of hepatocellular carcinoma cell line HCC-LY5
09/26/2012CN102690784A Establishment and application of hepatocellular carcinoma cell line HCC-LY10
09/26/2012CN102690328A Single photon emission computed tomography developer and preparation method thereof
09/26/2012CN102688507A Disinfection and sterilization couplant and its preparation method
09/26/2012CN102688506A Gastrointestinal contrast agent containing Chinese herbal extracts
09/26/2012CN102688505A Composition and reagent for detecting intragastric distribution of helicobacter pylori
09/26/2012CN101885913B Nanoparticles of light emissive polymers and preparation method thereof
09/25/2012USRE43688 Compositions and methods related to serotonin 5-HT1A receptors
09/25/2012US8273328 Antigen binding molecules that bind EGFR, vectors encoding same, and uses thereof
09/25/2012US8273327 Radio-opaque compounds, compositions containing same and methods of their synthesis and use
09/25/2012US8273326 Imaging infection with compounds that bind to thymidine kinase
1 ... 34 35 36 37 38 39 40 41 42 43 44 45 46 47 48 49 50 51 52 53 54 ... 354